Supplied as a prefilled oral dosing applicator-only presentation

Same 2-Dose Schedule1

ROTARIX Hero Image


ROTARIX is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) when administered as a 2-dose series. ROTARIX is approved for use in infants 6 weeks and up to 24 weeks of age.

Learn more about the liquid formulation1

Formulation Fully liquid formulation
No reconstitution necessary
Number of doses to complete the series Just 2 doses for series completion
Dose volume 1.5 mL
Administration Supplied in an oral dosing applicator
Flexible dosing schedule Dosing can begin at 6 weeks of age and should be completed by 24 weeks